WDR45 mutations also compromise lysosomal function, as evidenced by reduced levels of lysosomal markers LAMP1 and LAMP2, along with defective lysosomal activity, in fibroblasts from BPAN patients [84]. The gene discussed is WDR45; the disease is neurodegeneration with brain iron accumulation 5.